Efficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal Lymphoma
about
Nanomedicine in the application of uveal melanomaIntensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma.Diagnostic vitrectomy for primary intraocular lymphoma: when, why, how?Present and future treatment options for primary CNS lymphoma.How we diagnose and treat vitreoretinal lymphoma.Primary Vitreoretinal Lymphoma: Management of Isolated Ocular Disease.Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma.Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
P2860
Q28079572-67AEF67C-D12C-4537-B4D0-C69804A116F0Q33426914-2C0A9A19-0891-46E0-9699-AA5343A269F1Q38194808-50D914CD-799F-491F-9570-A1F673AD511EQ38587122-85D9212D-2A66-4190-A661-DE211E9E7155Q38822438-5C5CF017-5E47-46B9-818E-FA7F71B6491FQ38842910-2B13CF19-6194-4784-964A-F1125931E15DQ42336636-A2118309-EB7A-4BA8-BA62-D151A9B3B188Q58450924-2F0BF47C-580F-4F44-9F63-778C8847E764
P2860
Efficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal Lymphoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and Complications of ...... Primary Vitreoretinal Lymphoma
@en
Efficacy and Complications of ...... rimary Vitreoretinal Lymphoma.
@nl
type
label
Efficacy and Complications of ...... Primary Vitreoretinal Lymphoma
@en
Efficacy and Complications of ...... rimary Vitreoretinal Lymphoma.
@nl
prefLabel
Efficacy and Complications of ...... Primary Vitreoretinal Lymphoma
@en
Efficacy and Complications of ...... rimary Vitreoretinal Lymphoma.
@nl
P2093
P2860
P356
P1476
Efficacy and Complications of ...... Primary Vitreoretinal Lymphoma
@en
P2093
Kohji Nishida
Nobuyuki Ohguro
Noriyasu Hashida
P2860
P356
10.1167/TVST.1.3.1
P577
2012-10-22T00:00:00Z